[HTML][HTML] Artificial blood: the history and current perspectives of blood substitutes

F Khan, K Singh, MT Friedman - Discoveries, 2020 - ncbi.nlm.nih.gov
Blood transfusions are one of the most common procedures performed in hospitalized
patients. Yet, despite all of the measures taken to ensure the safety of the blood supply …

Blood substitutes and oxygen therapeutics: a review

JS Jahr, NR Guinn, DR Lowery… - Anesthesia & …, 2021 - journals.lww.com
Despite the exhaustive search for an acceptable substitute to erythrocyte transfusion, neither
chemical-based products such as perfluorocarbons nor hemoglobin-based oxygen carriers …

[HTML][HTML] Targeting the heme oxygenase 1/carbon monoxide pathway to resolve lung hyper-inflammation and restore a regulated immune response in cystic fibrosis

C Di Pietro, HH Öz, TS Murray… - Frontiers in …, 2020 - frontiersin.org
In individuals with cystic fibrosis (CF), lung hyper-inflammation starts early in life and is
perpetuated by mucus obstruction and persistent bacterial infections. The continuous tissue …

Where is the clinical breakthrough of heme oxygenase-1/carbon monoxide therapeutics?

CP Hopper, L Meinel, C Steiger… - Current pharmaceutical …, 2018 - ingentaconnect.com
Heme oxygenase (HO), the rate-limiting step in the degradation of heme to biliverdin, ferrous
ion, and carbon monoxide (CO), is an ancestral protective enzyme conserved across …

[HTML][HTML] Recruitment of monocytes primed to express heme oxygenase-1 ameliorates pathological lung inflammation in cystic fibrosis

C Di Pietro, HH Öz, P Zhang, E Cheng… - … & Molecular Medicine, 2022 - nature.com
Overwhelming neutrophilic inflammation is a leading cause of lung damage in many
pulmonary diseases, including cystic fibrosis (CF). The heme oxygenase-1 (HO-1)/carbon …

[HTML][HTML] Fine tuning of neurointensive care in aneurysmal subarachnoid hemorrhage: From one-size-fits-all towards individualized care

TS Wettervik, A Lewén, P Enblad - World Neurosurgery: X, 2023 - Elsevier
Aneurysmal subarachnoid hemorrhage (aSAH) is a severe type of acute brain injury with
high mortality and burden of neurological sequelae. General management aims at early …

Alternatives to transfusion: A case report and brief history of artificial oxygen carriers

SE Bachert, P Dogra, LI Boral - American Journal of Clinical …, 2020 - academic.oup.com
Objectives We discuss two main categories of blood substitutes: perfluorocarbons and
hemoglobin-based oxygen carriers. Methods We provide a review of the notable products …

Investigational drugs for vasospasm after subarachnoid hemorrhage

RT Tallarico, MA Pizzi, WD Freeman - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Aneurysmal subarachnoid hemorrhage (aSAH) represents 3% of all strokes in
the US. When the patient survives it can lead to permanent incapacity especially if the …

Use of hemoglobin for delivering exogenous carbon monoxide in medicinal applications

K Taguchi, T Maruyama… - Current Medicinal …, 2020 - ingentaconnect.com
Carbon Monoxide (CO), at low concentrations, can have a variety of positive effects on the
body including anti-apoptosis, anti-inflammatory, anti-oxidative and anti-proliferative effects …

Proceedings From the Society for Advancement of Blood Management Annual Meeting 2017: Management Dilemmas of the Surgical Patient—When Blood Is Not an …

GM Tan, NR Guinn, SM Frank… - Anesthesia & Analgesia, 2019 - journals.lww.com
Vigilance is essential in the perioperative period. When blood is not an option for the patient,
especially in a procedure/surgery that normally holds a risk for blood transfusion, complexity …